Ligand Pharmaceuticals Dividends
| LGND Stock | USD 116.55 2.09 1.76% |
The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to 13.31, whereas Dividends Paid is forecasted to decline to about 4.3 M. Ligand Pharmaceuticals' past performance could be the main factor of why investors trade Ligand Pharmaceuticals Incorporated stock today. Investors should clearly understand every aspect of the Ligand Pharmaceuticals dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Ligand Pharmaceuticals' dividend schedule and payout information. Ligand Pharmaceuticals Incorporated dividends can also provide a clue to the current valuation of Ligand Pharmaceuticals.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 4.5 M | 4.3 M | |
| Dividend Yield | 0.48 | 0.42 | |
| Dividend Payout Ratio | 0.81 | 0.72 | |
| Dividend Paid And Capex Coverage Ratio | 12.67 | 13.31 |
Ligand |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Ligand Pharmaceuticals must own a stock before its ex-dividend date to receive its next dividend.
Ligand Pharmaceuticals Dividends Paid Over Time
Today, most investors in Ligand Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ligand Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Ligand Pharmaceuticals dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Ligand Pharmaceuticals Historical Dividend Yield Growth
A solid dividend growth pattern of Ligand Pharmaceuticals could indicate future dividend growth is likely, which can signal long-term profitability for Ligand Pharmaceuticals Incorporated. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Ligand Pharmaceuticals Incorporated dividend as a percentage of Ligand Pharmaceuticals stock price. Ligand Pharmaceuticals dividend yield is a measure of Ligand Pharmaceuticals stock productivity, which can be interpreted as interest rate earned on an Ligand Pharmaceuticals investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ligand Pharmaceuticals. If investors know Ligand will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ligand Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.032 | Earnings Share 2.49 | Revenue Per Share | Quarterly Revenue Growth 0.576 | Return On Assets |
The market value of Ligand Pharmaceuticals is measured differently than its book value, which is the value of Ligand that is recorded on the company's balance sheet. Investors also form their own opinion of Ligand Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ligand Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ligand Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ligand Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ligand Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ligand Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ligand Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.